1. Home
  2. XBIT vs TWIN Comparison

XBIT vs TWIN Comparison

Compare XBIT & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

SELL

Current Price

$2.12

Market Cap

69.8M

Sector

Health Care

ML Signal

SELL

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

SELL

Current Price

$24.50

Market Cap

320.9M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
XBIT
TWIN
Founded
2005
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
320.9M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
XBIT
TWIN
Price
$2.12
$24.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
37.4K
★ 71.0K
Earning Date
11-11-2026
11-04-2026
Dividend Yield
N/A
★ 0.63%
EPS Growth
N/A
★ 1428.57
EPS
N/A
★ 1.86
Revenue
N/A
★ $381,270,000.00
Revenue This Year
N/A
$7.56
Revenue Next Year
$30.47
$8.00
P/E Ratio
★ N/A
$13.63
Revenue Growth
N/A
★ 11.90
52 Week Low
$2.09
$14.22
52 Week High
$3.44
$29.24

Technical Indicators

Market Signals
Indicator
XBIT
TWIN
Relative Strength Index (RSI) 39.61 40.88
Support Level N/A $21.86
Resistance Level $2.46 $25.50
Average True Range (ATR) 0.07 1.07
MACD -0.00 -0.35
Stochastic Oscillator 4.55 3.72

Price Performance

Historical Comparison
XBIT
TWIN

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: